Press Resease

Immuno Oncology Assays Market - Global Industry Analysis

Immuno Oncology Assays Market by Product (Consumables and Software), by Assay (Cell Migration & Invasion, Cell Proliferation, Immune Cell Killing, Phagocytosis, and Others), by Technology (PCR, Immunoassay, NGS, Flow Cytometry, and Others), by Indication (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Other Cancers), and by Application (Clinical Diagnostics and Research Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 27-May-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3963 Status : Published

Global immuno oncology assays market expected to generate around USD 6.63 billion by 2025, at a CAGR of around 12.9% between 2019 and 2025. The worldwide demand for immunology-based oncology assays is growing swiftly, owing to the increasing cancer prevalence, rising acceptance of targeted therapy, and growing demand for monoclonal antibodies (mAb).

Description

The report covers a forecast and an analysis of the immuno oncology assays market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the immuno oncology assays market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immuno oncology assays market on a global and regional level.

In order to give the users of this report a comprehensive view of the immuno oncology assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immuno Oncology Assays Market

The report provides company market share analysis to give a broader overview of the key players in the immuno oncology assays market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immuno oncology assays market on a global and regional basis.

The study provides a decisive view of the immuno oncology assays market by segmenting it based on product, assay, technology, indication, application, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some major players operating in the global immuno oncology assays market include Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.

This report segments the global immuno oncology assays market into:

Global Immuno Oncology Assays Market: By Product

  • Consumables
  • Software

Global Immuno Oncology Assays Market: By Assay

  • Cell Proliferation
  • Cell Migration and Invasion
  • Phagocytosis
  • Immune Cell Killing
  • Other

Global Immuno Oncology Assays Market: By Technology

  • PCR
  • Immunoassay
  • NGS
  • Flow Cytometry
  • Others

Global Immuno Oncology Assays Market: By Indication

  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Bladder Cancer
  • Other Cancers

Global Immuno Oncology Assays Market: By Application

  • Research Applications
  • Clinical Diagnostics

Global Immuno Oncology Assays Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Immuno Oncology Assays Market Revenue, 2016-2025 (USD Million)
    • 2.2. Global Immuno Oncology Assays Market: Snapshot
  •  
  • Chapter 3. Immuno Oncology Assays Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Immuno Oncology Assays Market drivers: Impact analysis
      • 3.2.2. Increasing Prevalence of Cancer
      • 3.2.3. Rising adoption of targeted therapy
    • 3.3. Market Restraints
      • 3.3.1. High capital investments
    • 3.4. Opportunities
      • 3.4.1. Emerging markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Product
      • 3.6.2. Market attractiveness analysis, by Assay
      • 3.6.3. Market attractiveness analysis, by Technology
      • 3.6.4. Market attractiveness analysis, by Indication
      • 3.6.5. Market attractiveness analysis, by Application
      • 3.6.6. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Immuno Oncology Assays Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Immuno Oncology Assays Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Immuno Oncology Assays Market - Product Analysis
    • 5.1. Global Immuno Oncology Assays Market: Product overview
      • 5.1.1. Global Immuno Oncology Assays Market revenue share, by Product, 2018 and 2025
    • 5.2. Consumables
      • 5.2.1. Global Immuno Oncology Assays Market for Consumables, 2016-2025 (USD Million)
    • 5.3. Software
      • 5.3.1. Global Immuno Oncology Assays Market for Software, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Immuno Oncology Assays Market - Assay Analysis
    • 6.1. Global Immuno Oncology Assays Market: Assay overview
      • 6.1.1. Global Immuno Oncology Assays Market revenue share, by Assay, 2018 and 2025
    • 6.2. Cell Proliferation
      • 6.2.1. Global Immuno Oncology Assays Market for Cell Proliferation, 2016-2025 (USD Million)
    • 6.3. Cell Migration & Invasion
      • 6.3.1. Global Immuno Oncology Assays Market for Cell Migration & Invasion, 2016-2025 (USD Million)
    • 6.4. Phagocytosis
      • 6.4.1. Global Immuno Oncology Assays Market for Phagocytosis, 2016-2025 (USD Million)
    • 6.5. Immune Cell Killing
      • 6.5.1. Global Immuno Oncology Assays Market for Immune Cell Killing, 2016-2025 (USD Million)
    • 6.6. Others
      • 6.6.1. Global Immuno Oncology Assays Market for Others, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Immuno Oncology Assays Market - Technology Analysis
    • 7.1. Global Immuno Oncology Assays Market: Technology overview
      • 7.1.1. Global Immuno Oncology Assays Market revenue share, by Technology, 2018 and 2025
    • 7.2. PCR
      • 7.2.1. Global Immuno Oncology Assays Market for PCR, 2016-2025 (USD Million)
    • 7.3. Immunoassay
      • 7.3.1. Global Immuno Oncology Assays Market for Immunoassay, 2016-2025 (USD Million)
    • 7.4. NGS
      • 7.4.1. Global Immuno Oncology Assays Market for NGS, 2016-2025 (USD Million)
    • 7.5. Flow Cytometry
      • 7.5.1. Global Immuno Oncology Assays Market for Flow Cytometry, 2016-2025 (USD Million)
    • 7.6. Others
      • 7.6.1. Global Immuno Oncology Assays Market for Others, 2016-2025 (USD Million)
  •  
  • Chapter 8. Global Immuno Oncology Assays Market - Indication Analysis
    • 8.1. Global Immuno Oncology Assays Market: Indication overview
      • 8.1.1. Global Immuno Oncology Assays Market revenue share, by Indication, 2018 and 2025
    • 8.2. Lung Cancer
      • 8.2.1. Global Immuno Oncology Assays Market for Lung Cancer, 2016-2025 (USD Million)
    • 8.3. Colorectal Cancer
      • 8.3.1. Global Immuno Oncology Assays Market for Colorectal Cancer, 2016-2025 (USD Million)
    • 8.4. Melanoma
      • 8.4.1. Global Immuno Oncology Assays Market for Melanoma, 2016-2025 (USD Million)
    • 8.5. Bladder Cancer
      • 8.5.1. Global Immuno Oncology Assays Market for Bladder Cancer, 2016-2025 (USD Million)
    • 8.6. Other Cancers
      • 8.6.1. Global Immuno Oncology Assays Market for Other Cancers, 2016-2025 (USD Million)
  •  
  • Chapter 9. Global Immuno Oncology Assays Market - Application Analysis
    • 9.1. Global Immuno Oncology Assays Market: Application overview
      • 9.1.1. Global Immuno Oncology Assays Market revenue share, by Application, 2018 and 2025
    • 9.2. Research Applications
      • 9.2.1. Global Immuno Oncology Assays Market for Research Applications, 2016-2025 (USD Million)
    • 9.3. Clinical Diagnostics
      • 9.3.1. Global Immuno Oncology Assays Market for Clinical Diagnostics, 2016-2025 (USD Million)
  •  
  • Chapter 10. Global Immuno Oncology Assays Market - Regional Analysis
    • 10.1. Global Immuno Oncology Assays Market: Regional overview
      • 10.1.1. Global Immuno Oncology Assays Market revenue share, by region, 2018 and 2025
    • 10.2. North America
      • 10.2.1. North America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
      • 10.2.2. North America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
      • 10.2.3. North America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
      • 10.2.4. North America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
      • 10.2.5. North America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.2.6. The U.S.
        • 10.2.6.1. The U.S. Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.2.6.2. The U.S. Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.2.6.3. The U.S. Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.2.6.4. The U.S. Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.2.6.5. The U.S. Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.2.7. Rest of North America
        • 10.2.7.1. Rest of North America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.2.7.2. Rest of North America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.2.7.3. Rest of North America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.2.7.4. Rest of North America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.2.7.5. Rest of North America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.3. Europe
      • 10.3.1. Europe Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
      • 10.3.2. Europe Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
      • 10.3.3. Europe Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
      • 10.3.4. Europe Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
      • 10.3.5. Europe Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.6. Germany
        • 10.3.6.1. Germany Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.3.6.2. Germany Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.3.6.3. Germany Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.3.6.4. Germany Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.3.6.5. Germany Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.7. U.K.
        • 10.3.7.1. U.K. Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.3.7.2. U.K. Immuno Oncology Assays MarketRevenue, by Assay, 2016-2025 (USD Million)
        • 10.3.7.3. U.K. Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.3.7.4. U.K. Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.3.7.5. U.K. Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.8. France
        • 10.3.8.1. France Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.3.8.2. France Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.3.8.3. France Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.3.8.4. France Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.3.8.5. France Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.3.9. Rest of Europe
        • 10.3.9.1. Rest of Europe Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.3.9.2. Rest of Europe Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.3.9.3. Rest of Europe Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.3.9.4. Rest of Europe Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.3.9.5. Rest of Europe Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
      • 10.4.2. Asia Pacific Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
      • 10.4.3. Asia Pacific Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
      • 10.4.4. Asia Pacific Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
      • 10.4.5. Asia Pacific Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.6. China
        • 10.4.6.1. China Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.4.6.2. China Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.4.6.3. China Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.4.6.4. China Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.4.6.5. China Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.7. Japan
        • 10.4.7.1. Japan Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.4.7.2. Japan Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.4.7.3. Japan Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.4.7.4. Japan Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.4.7.5. Japan Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.8. India
        • 10.4.8.1. India Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.4.8.2. India Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.4.8.3. India Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.4.8.4. India Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.4.8.5. India Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.4.9. Rest of Asia Pacific
        • 10.4.9.1. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.4.9.2. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.4.9.3. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.4.9.4. Rest of Asia Pacific Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.4.9.5. Rest of Asia Pacific Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.5. Latin America
      • 10.5.1. Latin America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
      • 10.5.2. Latin America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
      • 10.5.3. Latin America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
      • 10.5.4. Latin America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
      • 10.5.5. Latin America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.5.6.2. Brazil Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.5.6.3. Brazil Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.5.6.4. Brazil Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.5.6.5. Brazil Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
      • 10.5.7. Rest of Latin America
        • 10.5.7.1. Rest of Latin America Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
        • 10.5.7.2. Rest of Latin America Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
        • 10.5.7.3. Rest of Latin America Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
        • 10.5.7.4. Rest of Latin America Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
        • 10.5.7.5. Rest of Latin America Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Product, 2016-2025 (USD Million)
      • 10.6.2. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Assay, 2016-2025 (USD Million)
      • 10.6.3. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Technology, 2016-2025 (USD Million)
      • 10.6.4. The Middle East and Africa Immuno Oncology Assays Market revenue, by Indication, 2016-2025 (USD Million)
      • 10.6.5. The Middle East and Africa Immuno Oncology Assays Market Revenue, by Application, 2016-2025 (USD Million)
  •  
  • Chapter 11. Company Profile
    • 11.1. Thermo Fisher Scientific
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product Portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Agilent Technologies
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product Portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Roche Diagnostics
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product Portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Nanostring Technologies
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product Portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. Illumina
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product Portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. Foundation Medicine
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product Portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. Sartorius
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Product Portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Qiagen
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Product Portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments
    • 11.9. HTG Molecular Diagnostics
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Product Portfolio
      • 11.9.4. Business strategy
      • 11.9.5. Recent developments
    • 11.10. PerkinElmer
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Product Portfolio
      • 11.10.4. Business strategy
      • 11.10.5. Recent developments
    • 11.11. Merck
      • 11.11.1. Overview
      • 11.11.2. Financials
      • 11.11.3. Product Portfolio
      • 11.11.4. Business strategy
      • 11.11.5. Recent developments

Methodology

Free Analysis

Immuno-oncology deals with investigating the body’s immune system in response to cancer cells. Immuno-oncology assays are in-vitro assays that are used to study a drug’s or compound’s response in a tumor’s microenvironment. Critical information is obtained with optimized cell-based assays to validate the efficacy of a drug/compound. Immuno oncology assays play an important role in clinical diagnostics of cancer and drug discovery applications.

The worldwide demand for immunology-based oncology assays is growing swiftly, owing to the increasing cancer prevalence, rising acceptance of targeted therapy, and growing demand for monoclonal antibodies (mAb). Additionally, the rising levels of cancer awareness and the increasing number of government initiatives and funding for early cancer diagnosis research are propelling the immuno oncology assays market growth. However, huge capital investments and high immunotherapy treatment cost may restrain the immuno oncology assays market development. Replacement of chemotherapy with immunotherapy as the first line of therapy and emerging markets may bring new opportunities in the immuno oncology assays market in the future.

Global Immuno Oncology Assays Market

The global immuno oncology assays market is fragmented based on product, assay, technology, indication, and application. By product, the market includes consumables (reagents and kits, various accessories, etc.) and software. By assay, the market includes cell migration and invasion, cell proliferation, immune cell killing, phagocytosis, and others. Based on technology, the market includes polymerase chain reaction (PCR), immunoassay, flow cytometry, next-generation sequencing (NGS), and others. Based on indication, the market includes colorectal cancer, lung cancer, bladder cancer, melanoma, and other cancers. By application, global immuno oncology assays market is segmented into research applications and clinical diagnostics.

North America dominated the global immuno oncology assays market with a revenue share of almost 40% in 2018. This huge revenue share is accredited to the increasing prevalence of cancer, the presence of advanced healthcare infrastructure, and rising adoption of targeted therapy. North America is estimated to remain at the top market position over the forecast time period as well, owing to the increasing public and private funding for various R&D activities. Europe contributed the second largest revenue share in 2018 to the global immuno oncology assays market, due to rising cancer burden, growing adoption of technologically advanced products, and increasing healthcare spending. The Asia Pacific immuno oncology assays market will register the highest CAGR in the years ahead, owing to the increasing aging population base, rising cancer prevalence, and ongoing cancer therapy clinical trials.

Some major players operating in the global immuno oncology assays market include Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social